Wound Treatments in France

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN FRANCE
• Executive Summary
• Slow Growth
• De-reimbursement Limited Impact
• Pharmacies Stronghold Lessening
• Changing Mentalities
• Potential Growth
• Key Trends and Developments
• OTC Products in Difficult Trading Conditions
• Demographic Trends Impact Demand
• De-reimbursement: Does It Work?
• Economic Growth Increases Visits To Private Doctors
• Hectic Lifestyles and Rising Health Awareness Drive Sales
• Market Indicators
  • Table 1 Life Expectancy at Birth 2001-2006
• Market Data
  • Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
  • Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
  • Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
  • Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
  • Table 6 Penetration of Private Label by Sector 2002-2006
  • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
  • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
  • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
  • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
• Appendix
• OTC Registration and Classification
• Advertising
• Packaging and Labelling
• Distribution
• De-listing Or De-reimbursement
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Consumer Expenditure on Health Goods and Medical Services
  • Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
• Definitions
• Sources
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - FRANCE
• Arkopharma Sa, Laboratoires Pharmaceutiques
• Strategic Direction
• Key Facts
  • Summary 2 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts
  • Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators 2004-2006
• Company Background
• Production
• Competitive Positioning
  • Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2006
• Beaufour-ipsen SA
• Strategic Direction
• Key Facts
  • Summary 5 Beaufour-Ipsen SA: Key Facts
  • Summary 6 Beaufour-Ipsen SA: Operational Indicators 2004-2006
• Company Background
• Production
  • Summary 7 Beaufour-Ipsen SA: Production Statistics 2006
• Competitive Positioning
  • Summary 8 Beaufour-Ipsen SA: Competitive Position 2006
• Juva Sante, Laboratoires
• Strategic Direction
• Key Facts
  • Summary 9 Juva Sante, Laboratoires: Key Facts
  • Summary 10 Juva Sante, Laboratoires: Operational Indicators 2004-2006
• Company Background
• Production
  • Summary 11 Juva Sante, Laboratoires: Production Statistics 2006
• Competitive Positioning
  • Summary 12 Juva Sante, Laboratoires: Competitive Position 2006
• Laboratoires Martin-johnson & Johnson-msd Sas
• Strategic Direction
• Key Facts
  • Summary 13 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts
  • Summary 14 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators 2004-2006
• Company Background
• Competitive Positioning
  • Summary 15 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2006
• Pfizer Sante Grand Public
• Strategic Direction
• Key Facts
  • Summary 16 Pfizer Sante Grand Public: Key Facts
  • Summary 17 Pfizer Sante Grand Public: Operational Indicators 2004-2006
• Company Background
• Production
• Competitive Positioning
  • Summary 18 Pfizer Sante Grand Public: Competitive Position 2006
• Pierre Fabre Sa, Laboratoires
• Strategic Direction
• Key Facts
  • Summary 19 Pierre Fabre SA, Laboratoires: Key Facts
  • Summary 20 Pierre Fabre SA, Laboratoires: Operational Indicators 2004-2006
• Company Background
• Production
  • Summary 21 Pierre Fabre SA, Laboratoires: Production Statistics 2006
• Competitive Positioning
  • Summary 22 Pierre Fabre SA, Laboratoires: Competitive Position 2006
• Theraplix SA
• Strategic Direction
• Key Facts
  • Summary 23 Theraplix SA: Key Facts
  • Summary 24 Theraplix SA: Operational Indicators 2004-2006
• Company Background
• Competitive Positioning
  • Summary 25 Theraplix SA: Competitive Position 2006
• Upsa, Laboratoires
• Strategic Direction
• Key Facts
  • Summary 26 UPSA Conseil SAS: Key Facts
  • Summary 27 UPSA Conseil SAS: Operational Indicators 2004-2006
• Company Background
• Production
• Competitive Positioning
  • Summary 28 UPSA, Laboratoires: Competitive Position 2006
• Urgo, Laboratoires
• Strategic Direction
• Key Facts
  • Summary 29 Urgo, Laboratoires: Key Facts
  • Summary 30 Urgo, Laboratoires: Operational Indicators 2004-2006
• Company Background
• Production
• Competitive Positioning
  • Summary 31 Urgo, Laboratoires: Competitive Position 2006
• WOUND TREATMENTS IN FRANCE
• Overview
• Sector Data
  • Table 12 Sales of Wound Treatments by Subsector: Value 2001-2006
  • Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
  • Table 14 Wound Treatments Company Shares by Retail Value 2002-2006
  • Table 15 Wound Treatments Brand Shares by Retail Value 2003-2006
  • Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
  • Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
• Wound treatments France